Google
IVA — INVENTIVA SA (Healthcare >> Biotechnology)
IVA FAQ
What is IVA's ROE?
INVENTIVA SA reports a Return on Equity (ROE) of 2,290.08%.
What is IVA's dividend yield?
INVENTIVA SA offers a dividend yield of 0.00%.
What is IVA's Deepscope Quality Score?
Deepscope rates IVA's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy IVA?
Deepscope's AI Timing Score for IVA is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does IVA belong to?
INVENTIVA SA is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 3.85
Price
0.05
(1.32%)
Day Change
|
|
|---|
IVA Chất lượng tổng thể của cố phiếu Khá ( Chất lượng = 62) và Thời điểm mua ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
Tỷ lệ ROA tương đối thấp
ROA quá thấp so với ROE
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt lắm , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Khá , ...
| Yếu tố Chất lượng |
|
51% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 88 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 3.85 |
| PBV / Sector |
-27.35 / 4.91
|
| Earning Per Share | -3.22 |
| PE / Sector |
N/A / 18.34
|
| PEG or PE/Growth / Sector |
N/A / 0.61
|
| Average 1M Daily Value |
2.62 M
GREAT
|
| Average 1W Daily Value |
2.91 M
GREAT
|
| Yếu tố Kỹ thuật |
|
28% |
| Sức khỏe tài chính |
|
41% |
| Khả năng kiếm lợi nhuận |
|
64% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-13 11:13:59 |
| Symbol | IVA |
| Name | INVENTIVA SA |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 208.95 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 794.00 / 9,034.83 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 50 rue de Dijon, Daix, France, 21121
Phone: 33 3 80 44 75 00
Website: https://inventivapharma.com
Employees: 69
Sector: Healthcare >> Biotechnology
Description: Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
